A high throughput screen for 17 Dermorphin peptides in equine and human urine and equine plasma
- 20 November 2013
- journal article
- Published by Wiley in Drug Testing and Analysis
- Vol. 6 (9), 909-921
- https://doi.org/10.1002/dta.1585
Abstract
The Dermorphins are a family of peptides that act as potent agonists of the opioid μ receptor. Originally identified as a seven amino acid peptide on the skin of the South American Phyllomedusa frog, peptide chemists have since developed a large number of Dermorphin variants, many with superior opioid activity to the original peptide. Dermorphins are unique among the peptide opioid agonists as they appear to have a limited ability to cross the blood brain barrier, producing effects on both the central and peripheral nervous systems. It is this ability of Dermorphins to provide central anaesthesia after intravenous or subcutaneous administration that allows their use as analogues of the opioid class of drugs. Recently, illicit use of the Dermorphin peptide in the racing industry has shown the need for an analytical method to control the use of these peptides. We present a high-throughput liquid chromatography-tandem mass spectrometry screen for 17 Dermorphin peptides in equine urine and plasma with limits of detection down to 5 pg/mL. The peptide extraction technique is also suitable for use in human urine.Keywords
Funding Information
- Victorian State Government (NA)
This publication has 21 references indexed in Scilit:
- Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphinePeptides, 2011
- Desirability function combining metabolic stability and functionality of peptidesJournal of Peptide Science, 2011
- Quantitative Analysis of the Intra- and Inter-Individual Variability of the Normal Urinary ProteomeJournal of Proteome Research, 2011
- Analytical characterization and comparison of the blood–brain barrier permeability of eight opioid peptidesPeptides, 2010
- The dermorphin peptide familyGeneral Pharmacology: The Vascular System, 1996
- N-terminal tetrapeptide of dermorphin and D-ARG-substituted tetrapeptides: Inactivation process of the antinociceptive activity by peptidaseLife Sciences, 1990
- Dermorphin analogs carrying an increased positive net charge in their "message" domain display extremely high .mu.-opioid receptor selectivityJournal of Medicinal Chemistry, 1989
- On the degradation of dermorphin and D-Arg2-dermorphin analogs by a soluble rat brain extractBiochemical and Biophysical Research Communications, 1985
- D-Arg2-dermorphin tetrapeptide analogs: A potent and long-lasting analgesic activity after subcutaneous administrationBiochemical and Biophysical Research Communications, 1984
- AMINO ACID COMPOSITION AND SEQUENCE OF DERMORPHIN, A NOVEL OPIATE‐LIKE PEPTIDE FROM THE SKIN OF PHYLLOMEDUSA SAUVAGEIInternational Journal of Peptide and Protein Research, 1981